ToeFx Inc.

We are thrilled to announce that a landmark clinical study evaluating the ToeFX light therapy system for severe onychomycosis was published this week in the Journal of the American Podiatric Medical Association (JAPMA), recognized among the top 10 podiatry journals in clinical podiatric medicine. 🎉

This is the largest clinical study to date evaluating light therapy for severe onychomycosis. The study evaluated 165 toenails with severe onychomycosis, with 72.7% achieving ≥3 mm of healthy nail growth or total clearance after 6 months. These results are comparable to the current standard of care, but with no risk of drug interferences and zero reported side effects, making it highly suitable for vulnerable patients with comorbidities.

The publication represents years of patient recruitment, treatment, follow-up, data collection, statistical analysis and scientific collaboration - bringing this work into the peer-reviewed scientific literature and adding to the growing body of evidence surrounding light therapy.

Our sincere thanks to Dr. Alexander Rabinovich, MD, FRCSC, Orthopaedic Surgeon, for leading the study, and Dr. Judy Wismer, MD, FRCPC, Board-Certified Dermatologist, for bringing her expertise and clinical experience to the research.

Thank you to Francesca Sarzetto, Lana Alcock, Lijun Liu and Prof. Jianping Xu for their statistical, administrative and PCR contributions, which were integral to the study.

And to our partners, clinical collaborators and participating patients, thank you for helping make this research possible. This milestone belongs to all of you!

We are incredibly proud of what this study represents.

Read the published study here: https://na3.hubs.ly/y0FQdp0

Patients are looking for answers. Clinics are looking for solutions that work. ToeFX delivers both. Become a ToeFX partner clinic: https://na3.hubs.ly/y0Bjp-0

Book a demo → https://na3.hubs.ly/y0Fwmy0
Meet the ToeFX team at Top Practices Summit 2026 and see how podiatry practices are turning onychomycosis care into a high ROI treatment model.

Fungal nails have frustrated patients and clinicians for decades. ToeFX is changing that. Give your clinic the solution patients have been waiting for.
Bring ToeFX to your clinic: https://na3.hubs.ly/y0Bjp50

Patients are tired of treatments that fall short. ToeFX gives clinics a powerful new answer for stubborn fungal nails.
Bring ToeFX innovation to your practice: https://na3.hubs.ly/y0BjnZ0

Day 1 at the Shuffle Off to Buffalo conference! 💙
The ToeFX team is here, connecting with podiatrists, sharing ideas, and talking all things toenail health and innovation.

One of today’s highlights: “Light at the End of the Toenail” - a presentation by Dr. Patricia Nicholas, featuring our clinical study and insights into photodisinfection for fungal nail infections.

📍 Come see us at the ToeFX booth! Let’s talk science, clinical outcomes, and what’s next in toenail care.

Save Your Seat: https://na3.hubs.ly/y0CFf40
Explore the future of photodisinfection & photobiomodulation in podiatry with ToeFX. Join Dr. Monika Yazdanian and Dr. Irit Van-Ham for a discussion on what’s next in podiatric care.

📅 Sept. 24, 2026 | 7:30 PM EST
🎟️ Free Webinar

The Shuffle Off to Buffalo Podiatric Medical Conference is right around the corner!
Join us September 18–19, 2026, to experience ToeFX’s innovative light-based technology firsthand, meet our team, and discover what it could bring to your practice.

See the innovation in action! Book a demo now: https://na3.hubs.ly/y0BB6h0

Join us at The Shuffle Off to Buffalo Podiatric Medical Conference, September 18–19, 2026.

Experience ToeFX technology firsthand, ask your questions, and discover what it could bring to your practice.

Ready to see it in action? Book a demo now: https://na3.hubs.ly/y0BB610

Podiatrists are finding the answer to one of the most challenging conditions to treat. ToeFX gives podiatrists a powerful way to treat tough cases, without pills, heat, or pain.
Bring ToeFX to your clinic: https://na3.hubs.ly/y0BjnP0